Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $3.76 USD
Change Today +0.225 / 6.37%
Volume 227.1K
RIGL On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 11:39 AM 06/3/15 All times are local (Market data is delayed by at least 15 minutes).

RIGL

Industry Average

Ratio data TTM as of 03/31/2015

Profitability - rigel pharmaceuticals inc (RIGL)

Return on Assets

Industry Comparison
-29.51%

Return on Equity

Industry Comparison
-57.77%

Return on Capital

Industry Comparison
-36.24%

Margin Analysis - rigel pharmaceuticals inc (RIGL)

Gross Margin

Industry Comparison
-537.98%

Levered Free Cash Flow Margin

Industry Comparison
-148.93%

EBITDA Margin

Industry Comparison
-814.79%

SG&A Margin

Industry Comparison
208.11%

Asset Turnover - rigel pharmaceuticals inc (RIGL)

Total Assets Turnover

Industry Comparison
0.1x

Accounts Receivables Turnover

Industry Comparison
--
No data available

Fixed Assets Turnover

Industry Comparison
3.4x

Inventory Turnover

Industry Comparison
--
No data available

Credit Ratios - rigel pharmaceuticals inc (RIGL)

Current Ratio

Industry Comparison
4.7x

Quick Ratio

Industry Comparison
4.7x

Long-Term Solvency - rigel pharmaceuticals inc (RIGL)

Total Debt/Equity

Industry Comparison
--
No data available

Total Liabilities/Total Assets

Industry Comparison
32.31%

Growth Over Prior Year - rigel pharmaceuticals inc (RIGL)

Total Revenue

Industry Comparison
45.85%

Tangible Book Value

Industry Comparison
-40.45%

EBITDA

Industry Comparison
3.76%

Gross Profit

Industry Comparison
-13.33%

Receivables

Industry Comparison
--
No data available

Inventory

Industry Comparison
--
No data available

Diluted EPS Before Extra

Industry Comparison
1.04%

Capital Expenditures

Industry Comparison
-63.07%

Cash From Ops.

Industry Comparison
-54.34%

Levered Free Cash Flow

Industry Comparison
-64.69%
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RIGL:US $3.76 USD +0.23

RIGL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ArQule Inc $1.98 USD +0.16
CrystalGenomics Inc 15,250 KRW -500.00
CTI BioPharma Corp $2.15 USD +0.035
Exelixis Inc $3.26 USD -0.085
Progenics Pharmaceuticals Inc $5.86 USD +0.31
View Industry Companies
 

Industry Analysis

RIGL

Industry Average

Valuation RIGL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 29.6x
Price/Book 2.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 14.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RIGEL PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.